VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 43 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,046 | -86.8% | 17,930 | -79.5% | 0.00% | -87.5% |
| Q2 2023 | $2,079,722 | -32.7% | 87,420 | -28.1% | 0.01% | -82.6% |
| Q1 2023 | $3,092,410 | +115.9% | 121,557 | +147.9% | 0.05% | +70.4% |
| Q4 2022 | $1,432,517 | -63.4% | 49,042 | -74.3% | 0.03% | -64.0% |
| Q3 2022 | $3,918,000 | +89.7% | 191,029 | +7.0% | 0.08% | +31.6% |
| Q2 2022 | $2,065,000 | -31.2% | 178,451 | +10.0% | 0.06% | -28.8% |
| Q1 2022 | $3,001,000 | +37.8% | 162,281 | +47.3% | 0.08% | +17.6% |
| Q4 2021 | $2,178,000 | +488.6% | 110,175 | +389.6% | 0.07% | +580.0% |
| Q3 2021 | $370,000 | – | 22,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |